华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03320 华润医药

交易中 04-17 13:03:22

4.870

+0.020

+0.41%

最高4.890	最低4.810	成交量297.10万
今开4.850	昨收4.850	日振幅1.65%
总市值305.96亿	流通市值305.96亿	总股本62.83亿
成交额1,444万	换手率0.05%	流通股本62.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.87,"timestamp":1744866195451,"preClose":4.85,"halted":0,"volume":2971000,"delay":0,"floatShares":6282510461,"shares":6282510461,"eps":0.5629794245665233,"marketStatus":"交易中","change":0.02,"latestTime":"04-17 13:03:22","open":4.85,"high":4.89,"low":4.81,"amount":14442485,"amplitude":0.016495,"askPrice":4.87,"askSize":27500,"bidPrice":4.86,"bidSize":97500,"shortable":3,"etf":0,"ttmEps":0.5629794245665233,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1744877400000},"marketStatusCode":2,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.85,"dividendRate":0.029475,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.449517,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"2527298514","title":"华润医药04月16日主力净流出724万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2527298514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527298514?lang=zh_cn&edition=full","pubTime":"2025-04-16 16:16","pubTimestamp":1744791409,"startTime":"0","endTime":"0","summary":"04月16日, 华润医药股价跌2.22%，报收4.85元，成交金额8425万元，换手率0.28%，振幅3.63%，量比1.13。华润医药今日主力资金净流出724万元，上一交易日主力净流入563万元。该股近5个交易日下跌2.83%，主力资金累计净流入4075万元；近20日主力资金累计净流入1778万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416174025a45aec19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416174025a45aec19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2527292409","title":"“并购狂人”华润医药，开始甩包袱了","url":"https://stock-news.laohu8.com/highlight/detail?id=2527292409","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2527292409?lang=zh_cn&edition=full","pubTime":"2025-04-16 09:12","pubTimestamp":1744765927,"startTime":"0","endTime":"0","summary":"文源 | 源媒汇作者 | 胡青木编辑 | 苏淮“并购狂人”华润医药，开始卖资产了。然而，当所有人还在惊叹华润医药“买买买”的魄力时，这家央企却开始变卖资产了。因此在华润医药这一行业巨头入主后，双方的医药流通业务就出现了同业竞争问题。未来，博雅生物将继续聚焦血液制品主业，进一步巩固其在该领域的竞争优势，而华润医药的这一策略调整，或许也将为其他控股公司提供借鉴，甩掉亏损的非主营包袱，推动整个集团向高质量发展迈进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041609121994d6b512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041609121994d6b512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2518746362","title":"【华润医药(03320.HK)：昆药集团(600422.SH)2024年度股东应占净利润6.48亿元 同比增加19.86%】华润医药(03320.HK)发布昆药集团(600422.SH)截止2024年12月31日止年度的主要财务资料，营业总收入84.01亿元(人民币，下同)，同比减少0.34%;上市公司股东应占净利润6.48亿元，同比增加19.86%;每股基本盈利0.86元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746362","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518746362?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:41","pubTimestamp":1741696900,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK)发布昆药集团(600422.SH)截止2024年12月31日止年度的主要财务资料，营业总收入84.01亿元(人民币，下同)，同比减少0.34%;上市公司股东应占净利润6.48亿元，同比增加19.86%;每股基本盈利0.86元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11204148667927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03320","600422"],"gpt_icon":0},{"id":"2518074515","title":"华润医药(03320)：昆药集团(600422.SH)2024年度股东应占净利润6.48亿元 同比增加19.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518074515","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518074515?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:36","pubTimestamp":1741696590,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布昆药集团(600422.SH)截止2024年12月31日止年度的主要财务资料，营业总收入84.01亿元(人民币，下同)，同比减少0.34%;上市公司股东应占净利润6.48亿元，同比增加19.86%;每股基本盈利0.86元。经昆药集团董事会决定，昆药集团建议以实施权益分派股权登记日登记的总股本为基数，向全体昆药集团股东分派现金股息每10股人民币3.00元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600422","03320"],"gpt_icon":0},{"id":"2518718632","title":"华润医药03月11日获主力加仓177万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518718632","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518718632?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:17","pubTimestamp":1741681033,"startTime":"0","endTime":"0","summary":"03月11日, 华润医药股价涨0.95%，报收5.29元，成交金额3359万元，换手率0.10%，振幅2.86%，量比0.47。华润医药今日主力资金净流入177万元，上一交易日主力净流入124万元。该股近5个交易日上涨0.76%，主力资金累计净流出658万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出2420万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170422a1d4a061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170422a1d4a061&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2517105512","title":"华润医药03月07日主力净流出1052万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517105512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517105512?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335420,"startTime":"0","endTime":"0","summary":"03月07日, 华润医药股价跌0.93%，报收5.31元，成交金额6974万元，换手率0.21%，振幅2.05%，量比0.99。华润医药今日主力资金净流出1052万元，上一交易日主力净流入422万元。该股主力净额占比0.03%，港股市场排名2465/2653。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170913a263e0ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170913a263e0ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2514316910","title":"华润医药西部创新中心落地 成都高新区再添高能级医药项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2514316910","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514316910?lang=zh_cn&edition=full","pubTime":"2025-02-28 15:40","pubTimestamp":1740728424,"startTime":"0","endTime":"0","summary":"近日，成都高新区与华润医药在成都天府新城会议中心举行签约仪式，华润医药西部创新中心正式落地成都高新区。这标志着成都高新区与中国生物医药行业领军企业华润医药的合作进入实质性落地阶段，双方将携手共同推进华润医药在成都高新区打造全国创新药械研发制造高地，同时在细胞与基因治疗、核医药等医药健康未来赛道探索深入合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502283333161052.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502283333161052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1570","BK1574","09939","BK1161","03320","BK1515"],"gpt_icon":0},{"id":"2514842837","title":"华润医药想补上“创新”短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2514842837","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514842837?lang=zh_cn&edition=full","pubTime":"2025-02-27 14:15","pubTimestamp":1740636908,"startTime":"0","endTime":"0","summary":"由此看来，华润入主天士力，也是为了快速弥补技术短板，但后续双方也面临整合风险和成本问题。尽管华润医药在中药和大健康领域布局广泛，且通过并购不断扩张业务版图，但在创新药领域的短板，已成为其发展瓶颈。华润医药未来是否会加大创新药领域的投入，或通过并购等方式补齐创新短板，仍需观察。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022714152698947af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022714152698947af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2514588627","title":"博雅生物：华润医药签署南格尔生物科技控股权转让协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2514588627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514588627?lang=zh_cn&edition=full","pubTime":"2025-02-26 17:00","pubTimestamp":1740560433,"startTime":"0","endTime":"0","summary":"根据2025年2月24日的新闻报道，华润医药与成都天府国际生物城发展集团有限公司签订了关于南格尔生物科技的控股权转让协议。2025年2月24日，公司控股股东华润医药与成都天府国际生物城发展集团有限公司签署关于成都生物城集团旗下四川南格尔生物科技有限公司控股权转让协议，此次收购是华润医药在医疗器械及血液制品领域的重要战略布局，将进一步打造在血液制品领域包含设备生产、产品研发、浆站一体化的全产业链产业生态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022600029425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","BK1570","159837","03320","BK1191","BK0046","300294"],"gpt_icon":0},{"id":"2514079810","title":"博雅生物：此次收购是华润医药在医疗器械及血液制品领域的重要战略布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2514079810","media":"互动易","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514079810?lang=zh_cn&edition=full","pubTime":"2025-02-26 15:45","pubTimestamp":1740555902,"startTime":"0","endTime":"0","summary":"有投资者向博雅生物提问， 董秘，您好。2025年2月24日，公司控股股东华润医药与成都天府国际生物城发展集团有限公司签署关于成都生物城集团旗下四川南格尔生物科技有限公司控股权转让协议，此次收购是华润医药在医疗器械及血液制品领域的重要战略布局，将进一步打造在血液制品领域包含设备生产、产品研发、浆站一体化的全产业链产业生态。公司严格按照信息披露相关规则做好信息披露工作，该事项未涉及本公司信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226155620abdd7e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226155620abdd7e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09996","BK1570","03320","09997","BK1191","BK1100","BK1222","BK1583","BK1574"],"gpt_icon":0},{"id":"2513406714","title":"华润医药02月24日遭主力抛售417万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513406714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513406714?lang=zh_cn&edition=full","pubTime":"2025-02-24 16:16","pubTimestamp":1740384998,"startTime":"0","endTime":"0","summary":"02月24日, 华润医药股价跌0.18%，报收5.47元，成交金额8668万元，换手率0.25%，振幅2.55%，量比1.47。华润医药今日主力资金净流出417万元，连续3日净流出，上一交易日主力净流出29万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为62.50%，平均跌幅为1.53%。该股近5个交易日上涨0.92%，主力资金累计净流出1241万元；近20日主力资金累计净流出946万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224161755a251a1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224161755a251a1f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2512565291","title":"华润医药想补上“创新”短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2512565291","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512565291?lang=zh_cn&edition=full","pubTime":"2025-02-18 19:44","pubTimestamp":1739879099,"startTime":"0","endTime":"0","summary":"由此看来，华润入主天士力，也是为了快速弥补技术短板，但后续双方也面临整合风险和成本问题。尽管华润医药在中药和大健康领域布局广泛，且通过并购不断扩张业务版图，但在创新药领域的短板，已成为其发展瓶颈。华润医药未来是否会加大创新药领域的投入，或通过并购等方式补齐创新短板，仍需观察。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218195048a24a86ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218195048a24a86ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2512978964","title":"南向资金2月14日净买入华润医药46.45万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2512978964","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512978964?lang=zh_cn&edition=full","pubTime":"2025-02-17 09:30","pubTimestamp":1739755823,"startTime":"0","endTime":"0","summary":"2月14日, 南向资金增持华润医药46.45万股，连续3日增持。截止当日收盘，港股通共持有华润医药41604.51万股，占流通股6.61%。华润医药近5个交易日上涨3.23%，港股通累计增持355.15万股；近20个交易日上涨3.82%，港股通累计增持2044.75万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217093220abd18d48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217093220abd18d48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2510808551","title":"华润医药控股增持博雅生物股份，公司前三季度业绩承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2510808551","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510808551?lang=zh_cn&edition=full","pubTime":"2025-02-11 17:16","pubTimestamp":1739265361,"startTime":"0","endTime":"0","summary":"近日，博雅生物发布公告称，收到控股股东华润医药控股的告知函。华润医药控股于2024年11月8日至2025年2月7日期间，通过深圳证券交易所交易系统以集中竞价交易方式累计增持公司股份510.65万股，占公司总股本的1.0127%。尽管控股股东积极增持，但博雅生物2024年前三季度的业绩表现较为疲软。此次增持体现了华润医药控股对博雅生物未来发展的信心，但公司短期内仍面临较大的业绩压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211172212961f03ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211172212961f03ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2510587082","title":"华润医药(03320.HK)巯嘌呤片(II)获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2510587082","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510587082?lang=zh_cn&edition=full","pubTime":"2025-02-11 16:52","pubTimestamp":1739263920,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 宣布，集团旗下华润双鹤药业收到国家药品监督管理局颁发的巯嘌呤片(ＩＩ)《药品注册证书》，并获批上市。该药物适用于儿童急性淋巴细胞白血病(ALL)及急性非淋巴细胞白血病，慢性粒细胞白血病的急变期。(sl/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-11 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416374/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2510843195","title":"【港股通】华润医药(03320)：附属华润三九去年纯利约33.7亿元人民币 同比升18.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510843195","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510843195?lang=zh_cn&edition=full","pubTime":"2025-02-11 09:10","pubTimestamp":1739236216,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公布，附属公司华润三九截至去年12月31日止年度初步财务资料，纯利约33.7亿元(人民币，下同)，同比上升18.1%，每股盈利2.63元，扣除非经常性收益或亏损后的纯利31.2亿元，同比上升14.9%。期内，华润三九营业总收入276亿元，同比上升11.63%，营业利润约44.7亿元，同比上升19.28%。另外，集团连同华润三九合共持有约28.05%权益的昆药集团去年度纯利约6.5亿元，比2023年追溯调整前纯利同比上升45.74%，每股盈利86分，营业总收入84亿元，同比上升9%，营业利润9.3亿元，同比上升63.13%。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/MzFkZTQ1MjU5YjFkNTI3NmM3M2EwODA1ODY2NzgzMDk4MzEw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MzFkZTQ1MjU5YjFkNTI3NmM3M2EwODA1ODY2NzgzMDk4MzEw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1952858","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK0196","000999","03320","HSTECH","BK0175","BK1191","BK0060","BK0012","BK0010","YANG","BK0028","BK0185","BK0188","BK0183","BK0239","HSCEI"],"gpt_icon":0},{"id":"2510489248","title":"华润医药：华润三九2024年度股东应占净利润33.69亿元 同比增加18.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510489248","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510489248?lang=zh_cn&edition=full","pubTime":"2025-02-11 08:35","pubTimestamp":1739234100,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　华润医药（03320）发布公告，该集团附属公司华润三九（000999.SZ）截至2024年12月31日止年度取得营业总收入人民币276.17亿元（单位下同），同比增加11.63%；上市公司股东应占净利润33.69亿元，同比增加18.1%；每股基本盈利2.63元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-11/doc-inekafyk3510887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03320","000999"],"gpt_icon":0},{"id":"2510940848","title":"华润医药：昆药集团2024年股东应占净利润约6.48亿元 同比增长19.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510940848","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510940848?lang=zh_cn&edition=full","pubTime":"2025-02-11 08:34","pubTimestamp":1739234040,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　华润医药（03320）公布昆药集团2024年未经审核初步财务资料，营业总收入约84.01亿元，同比减少0.34%；上市公司股东应占净利润约6.48亿元，同比增长19.86%；每股基本盈利0.86元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-11/doc-inekafyr3631787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600422","03320"],"gpt_icon":0},{"id":"2510869717","title":"华润医药(03320.HK)附属昆药集团去年赚6.48亿人民币  增长19.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510869717","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510869717?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:34","pubTimestamp":1739201640,"startTime":"0","endTime":"0","summary":"华润医药公布，附属昆药集团2024年度初步业绩，营业总收入84.01亿人民币(下同)，较上年度微降0.3%。股东应占净利润6.48亿元，增长19.9%，每股盈利86分。(港股报价延迟最少十五分钟。沽空资料截至 2025-02-10 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩股息：人民币 0.0830 2024/03/26末期业绩股息：人民币 0.1540 2023/08/31中期业绩无派息2023/03/30末期业绩股息：港元 0.1600 AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416122/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1570","BK0060","BK0028","600422","BK1191","03320","BK0239","BK0188"],"gpt_icon":0},{"id":"2510921853","title":"华润医药2024年度净利润33.69亿元 同比增18.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510921853","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510921853?lang=zh_cn&edition=full","pubTime":"2025-02-10 19:30","pubTimestamp":1739187000,"startTime":"0","endTime":"0","summary":"财中社2月10日电华润医药 发布公告，2025年2月10日，华润三九公布了截至2024年12月31日止年度的未经审计初步财务资料。报告期内，华润三九实现营业总收入为276.17亿元，同比增长11.63%；营业利润为44.77亿元，同比增长19.28%；利润总额为45.96亿元，同比增长22.4%；上市公司股东应占净利润为33.69亿元，同比增长18.1%。每股基本盈利为2.63元，同比增长17.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210193234961dd5b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210193234961dd5b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.0202},{"period":"1month","weight":-0.1308},{"period":"3month","weight":-0.049},{"period":"6month","weight":-0.1623},{"period":"1year","weight":0.0615},{"period":"ytd","weight":-0.1491}],"compareEarnings":[{"period":"1week","weight":0.0391},{"period":"1month","weight":-0.1279},{"period":"3month","weight":0.0786},{"period":"6month","weight":0.0122},{"period":"1year","weight":0.2959},{"period":"ytd","weight":0.0497}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案，如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.016698},{"month":2,"riseRate":0.777778,"avgChangeRate":0.050412},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.026516},{"month":4,"riseRate":0.777778,"avgChangeRate":0.042774},{"month":5,"riseRate":0.5,"avgChangeRate":0.006748},{"month":6,"riseRate":0.375,"avgChangeRate":0.006122},{"month":7,"riseRate":0.125,"avgChangeRate":-0.056809},{"month":8,"riseRate":0.5,"avgChangeRate":0.011562},{"month":9,"riseRate":0.25,"avgChangeRate":-0.023565},{"month":10,"riseRate":0.125,"avgChangeRate":-0.03496},{"month":11,"riseRate":0.444444,"avgChangeRate":0.015631},{"month":12,"riseRate":0.555556,"avgChangeRate":0.006861}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}